Promephy - Metabolic Fate of Plant-based Proteins

NCT05669612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-02-05

No results posted yet for this study

Summary

The PROMEPHY study aims to assess differences between animal versus plant-based proteins on metabolic and physiological parameters in healthy adults. It is envisaged that the results from this study will provide important and novel insights into the potential health-benefits of regular consumption of plant-based proteins. This may enable future application in products available to the consumer.

The main objective of this study is to compare the changes in serum essential amino acid bioavailability after two weeks of daily consumption of a plant-based protein mix with the changes in serum essential amino acid bioavailability after two weeks of daily consumption of a milk protein isolate. In addition this study will aim to assess the impact of different protein sources on gut microbiota and proteome composition to determine the potential health impact of consumption of plant-based proteins.

Conditions

  • Amino Acid Change
  • Gastrointestinal Dysfunction

Interventions

DIETARY_SUPPLEMENT

Dairy based protein

Initial bioavailability trial, followed by 2 weeks consumption of product and follow up bioavailability trial

DIETARY_SUPPLEMENT

Mixed protein

Initial bioavailability trial, followed by 2 weeks consumption of product and follow up bioavailability trial

DIETARY_SUPPLEMENT

Plant-based protein 1

Initial bioavailability trial, followed by 2 weeks consumption of product and follow up bioavailability trial

DIETARY_SUPPLEMENT

Plant-based protein 2

Initial bioavailability trial, followed by 2 weeks consumption of product and follow up bioavailability trial

Sponsors & Collaborators

  • Danone Nutricia Research

    collaborator INDUSTRY
  • Anglia Ruskin University

    lead OTHER

Principal Investigators

  • Justin Roberts, PhD · Anglia Ruskin University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-02
Primary Completion
2024-02-17
Completion
2024-02-17

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05669612 on ClinicalTrials.gov